Market Snapshot
S&P Futures
3,809.5
Dow Futures
30,868
Nasdaq Futures
11,633.25
Acer Therapeutics Inc. (ACER) stock declined over -2.33% intraday to trade at $1.26 a share on NASDAQ. The stock opened with a loss of -2.33% at $1.3 and touched an intraday high of $1.3, falling -2.33% against the last close of $1.29. The stock went to a low of $1.21 during the session.
Prev. Close
Market Cap
Day Low
Open
Number of Shares
Day High
P/E ratio
EPS (TTM)
Cash Flow per Share
Free Float in %
Book Value
Volume
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
2022-06-30 | $1.3 | $1.3 | $1.21 | $1.26 | 82,886 |
2022-06-29 | $1.29 | $1.32 | $1.21 | $1.29 | 85,100 |
2022-06-28 | $1.43 | $1.45 | $1.25 | $1.36 | 208,300 |
2022-06-27 | $1.24 | $1.61 | $1.24 | $1.43 | 878,900 |
2022-06-24 | $1.2 | $1.28 | $1.2 | $1.22 | 171,000 |
2022-06-23 | $1.42 | $1.42 | $1.16 | $1.19 | 322,200 |
2022-06-22 | $1.41 | $1.41 | $1.31 | $1.31 | 146,300 |
2022-06-21 | $1.68 | $1.69 | $1.37 | $1.39 | 655,900 |
2022-06-17 | $1.79 | $1.85 | $1.75 | $1.76 | 61,100 |
2022-06-16 | $1.81 | $1.85 | $1.77 | $1.78 | 68,500 |
Employees-
Beta1.53
Sales or Revenue1.26 Million
5Y Sales Change-15.40%
Fiscal Year Ends2021-12-30
SectorHealth Care
IndustryPharmaceuticals
Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates: EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mutation; ACER-001, a formulation of sodium phenylbutyrate for the treatment of various inborn errors of metabolism, including urea cycle disorders and maple syrup urine disease; ACER-801 (osanetant) for the treatment of induced Vasomotor Symptoms; and ACER-2820 (emetine), a host-directed therapy against a variety of infectious diseases, including COVID-19. The company has a research collaboration agreement with the National Center for Advancing Translational Sciences (NCATS) to develop emetine hydrochloride as a potential treatment for patients with COVID-19; and a license agreement with Sanofi to acquire worldwide rights to osanetant, a clinical-stage, selective, and non-peptide tachykinin NK3 receptor antagonist. Acer Therapeutics Inc. was founded in 1991 and is headquartered in Newton, Massachusetts.
Acer Therapeutics Inc. (NASDAQ: ACER) stock price is $1.26 as of the last check on Thursday, June 30. During the trading session, ACER stock reached the peak price of $1.3 while $1.21 was the lowest point it dropped to.
The NASDAQ listed ACER is part of Pharmaceuticals industry that operates in the broader Health Care sector. Acer Therapeutics Inc. , a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases.
Mr. Christopher Schelling
Founder, Pres, CEO & Director
Mr. Harry S. Palmin
COO & CFO
Mr. Jefferson E. Davis
Chief Bus. Officer
Mr. John Michael Klopp
Chief Technical Officer
ACER stock traded closed the last session at $1.26, which is $-0.03 or -2.33% lower than its previous close of $1.29. ACER's current trading price is 8.30% lower than its 52-week high of $3.77 where as its distance from 52-week low of 1.16% is -66.58%.
Number of ACER employees currently stands at -. ACER operates from One Gateway Center, Suite 351, Newton, MA 02458, United States.
Official Webiste of $ACER is: https://www.acertx.com
ACER could be contacted at ACER operates from One Gateway Center, Suite 351, Newton, MA 02458, United States, or at phone #844 902 6100 and can also be accessed through its website.
ACER stock volume for the day was 82,966 shares while in the previous session number of ACER shares traded was 82,886 . The average number of ACER shares traded daily for last 3 months was 519.89 Thousands.
The percentage change in ACER stock occurred in the recent session was -2.33% while the dollar amount for the price change in ACER stock was $-0.03.
In the recent session, the day high for ACER stock was $1.3 while the low for ACER stock touched on the day was $1.21.
The market value of ACER currently stands at 21.9 Million with its latest stock price at $1.26 and 14.31 Million of its shares outstanding.